Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Intervention Study of the Effectiveness Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Against Vaccine Type Pneumococcal Hospitalised Community Acquired Pneumonia (CAP) in Adults 60 Years and Older Using A Test Negative Design Study in A Well-Defined Area of the South of Madrid Region

NCT04613375 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04613375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04613375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Intervention Study of the Effectiveness Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Against Vaccine Type Pneumococcal Hospitalised Community Acquired Pneumonia (CAP) in Adults 60 Years and Older Using A Test Negative Design Study in A Well-Defined Area of the South of Madrid Region
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
March 12, 2021
Completion date
March 24, 2024
Enrollment
1,821 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

community acquired pneumonia (cap)